VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

AAN 2021 | The importance of shared decision making in migraine

Shared decision making allows patients and healthcare professionals to work together to put patients at the center of decisions about their own treatment. Jessica Ailani, MD, FAAN, Medstar Georgetown University Hospital, Washington, DC, discusses key aspects of shared decision making in patients with migraine and the benefits of this approach. When involving patients in decision making, it is important to ensure they are fully supported and educated, with the benefits and risks of all options clearly presented. A back-and-forth dialogue with a patient should be maintained throughout. When this process is successfully implemented, it can give patients more confidence in their treatment plan, improving satisfaction and adherence. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.

Disclosures

Consulting: (Honoraria for independent consulting) Amgen, Abbvie, Biohaven, Eli Lilly and Company, Lundbeck, Teva, Impel, Satsuma, Theranica, Axsome, Neso, GlaxoSmithKline, Aeon, Medscape
Ownership of Stocks: CtrM
Speakers Bureau: (Honoraria for promotional speaking) Allergan/Abbvie, Amgen, Biohaven, Eli Lilly and Company, Lundbeck, Teva
Editorial services: (Honoraria) Current Pain and Headache Reports, Section editor, Unusual Headache Syndromes, NeurologyLive, SELF (medical reviewer)
Clinical Trial Grants: (Fees to Institution) American Migraine Foundation, Allergan, Biohaven, Eli Lilly and Company, Satsuma, Zosano